Healthy

Showing NaN - NaN of 135

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in New Haven (BIIB118)

Completed
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Feb 15, 2021

Healthy Trial in New Haven (330 mg pregabalin controlled release, 300 mg pregabalin immediate release)

Completed
  • Healthy
  • 330 mg pregabalin controlled release
  • 300 mg pregabalin immediate release
  • New Haven, Connecticut
    Pfizer Investigational Site
Jan 26, 2021

Healthy Trial in New Haven (Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg,

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, 600- 750 calorie
  • +2 more
  • New Haven, Connecticut
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in New Haven (Pregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg,

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, 400 to 500 calorie
  • +3 more
  • New Haven, Connecticut
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in New Haven (Pregabalin ER)

Completed
  • Healthy
  • Pregabalin ER
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Jan 15, 2021

Healthy Trial in New Haven (PF-07304814, Placebo)

Completed
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 4, 2021

Healthy Trial in New Haven (LY3372689, [18F]LSN3316612)

Completed
  • Healthy
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Nov 3, 2020

Healthy Trial in New Haven (tofacitinib modified release (MR))

Completed
  • Healthy
  • tofacitinib modified release (MR)
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Oct 27, 2020

Healthy Trial in New Haven (PF-06650833 alone, PF-06651600 alone, PF-06650833 together with PF-06651600)

Completed
  • Healthy
  • PF-06650833 alone
  • +2 more
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
May 18, 2020

Healthy Trial in New Haven (PF-05221304 Formulation A, PF-05221304 Formulation B)

Completed
  • Healthy
  • PF-05221304 Formulation A
  • PF-05221304 Formulation B
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
May 18, 2020

Healthy Trial in New Haven (LY3372689, [18F]LSN3316612)

Completed
  • Healthy
  • New Haven, Connecticut
    Invicro, Institute for Neurodegenerative Disorders
Apr 21, 2020

Healthy Trial in New Haven (flavor and sweetener, flavor and nicotine, flavor, nicotine and sweetener)

Completed
  • Healthy
  • flavor and sweetener
  • +3 more
  • New Haven, Connecticut
    The John B Pierce Laboratory
Mar 4, 2020

Nicotine Dependence, Healthy Trial in New Haven (Amphetamine)

Completed
  • Nicotine Dependence
  • Healthy
  • New Haven, Connecticut
    Yale University
Mar 4, 2020

Healthy Trial in New Haven (Tofacitinib tablet, Tofacitinib Oral Solution)

Completed
  • Healthy
  • Tofacitinib tablet
  • Tofacitinib Oral Solution
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 8, 2020

Healthy Trial in New Haven (PF-04958242, Itraconazole)

Completed
  • Healthy
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Dec 20, 2019

Healthy Trial in New Haven (PF-04958242, Placebo)

Completed
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Dec 23, 2019

Healthy Trial in New Haven (Glucose100, Glucose50, Glucose42)

Terminated
  • Healthy
  • Glucose100
  • +3 more
  • New Haven, Connecticut
    Yale Center for Clinical Investigation Church Street Research Un
Nov 25, 2019

Healthy Trial in New Haven (PF-04958242 capsule, PF-04958242 oral solution)

Completed
  • Healthy
  • PF-04958242 capsule
  • PF-04958242 oral solution
  • New Haven, Connecticut
    Pfizer Investigational Site
Nov 19, 2019

Healthy Trial in New Haven (PF-06946860, Placebo)

Completed
  • Healthy
  • PF-06946860
  • Placebo
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Nov 6, 2019

Healthy Trial in New Haven (PF-04965842, Probenecid)

Completed
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Oct 17, 2019

Healthy Trial in New Haven (Within-Subject Active vs Placebo Topical Applications, Within-Subject Active vs. Placebo Topical

Completed
  • Healthy
  • Within-Subject Active vs Placebo Topical Applications
  • Within-Subject Active vs. Placebo Topical Applications
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jun 21, 2019

Healthy Trial in New Haven (Positron Emission tomography, PET Scan with PF-03654746)

Completed
  • Healthy
  • Positron Emission tomography
  • PET Scan with PF-03654746
  • New Haven, Connecticut
  • +2 more
Feb 28, 2019

Healthy Trial in New Haven (PF-06463922, rifampin)

Completed
  • Healthy
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Aug 22, 2018

Healthy Trial in New Haven (PF-04447943, Placebo, Moxifloxacin)

Completed
  • Healthy
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Jun 18, 2018

Healthy Trial in New Haven (18F-JNJ-64326067)

Completed
  • Healthy
  • New Haven, Connecticut
    Molecular NeuroImaging
Nov 29, 2018